CG Oncology, Inc. (CGON) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $3.00M; Debt Instrument, Fee AmountUSD (m).
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $3.00M; Debt Instrument, Fee AmountUSD (m).
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD $3.00M; Debt Instrument, Fee AmountUSD (m).
- 2025-09-30: Long-term Debt, Excluding Current MaturitiesUSD $3.00M; Debt Instrument, Fee AmountUSD (m).
CG Oncology, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Debt Instrument, Fee Amount USD |
|---|---|---|
| 2026-06-30 | $3.00M | (m) |
| 2026-03-31 | $3.00M | (m) |
| 2025-12-31 | $3.00M | (m) |
| 2025-09-30 | $3.00M | (m) |
| 2024-12-31 | $0.00 | (m) |
| 2024-03-05 | (m) | $400.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |